OBJECTIVE: Percutaneous transcatheter embolization of @entity438 ( @entity438 ) has been widely accepted as the first line of treatment in @entity1 with symptoms, @entity397 , or large @entity439 size. Although embolization can usually be performed safely, @entity63 , such as @entity1188 or @entity733 , occur in some @entity1 . This study evaluated the feasibility and outcomes of endovascular @entity5475 repair (ESAAR) using stent grafts, which may allow treatment while preserving flow to the spleen. METHODS: We reviewed the clinical data of all consecutive @entity1 who underwent ESAAR using stent grafts. Brachial access was used except for @entity1 with favorable angle of origin from the aorta. To overcome tortuosity and provide support, a coaxial system with a hydrophilic sheath was used. Low-profile 0.018-inch stent grafts were used for distal @entity438 with a 10-mm to 15-mm length of proximal and distal segment of splenic artery measuring 4 to 11  mm in diameter. Follow-up included clinical examination and computed tomography imaging within 4 to 6  months after the procedure and yearly thereafter. End points were morbidity, stent graft patency, and freedom from @entity1070 and reinterventions. RESULTS: ESAAR was attempted in 10 @entity1 , four males and six females, with median age of 64  years (range, 48-77  years). Median @entity5475 size was 2.8  cm (range, 2-5.7  cm). Nine @entity1 were asymptomatic, and one had @entity788 and @entity360 . The arterial access site was the brachial artery in six @entity1 and the femoral artery in four. Two @entity1 had brachial and femoral access to facilitate splenic artery stenting. Technical success of ESAAR using stent grafts was 80% (8 of 10). In two @entity1 with distal @entity438 , stent graft placement was not possible due to excessive vessel tortuosity, and treatment was by coil embolization. One @entity1 developed @entity715 , which was treated surgically. There were no @entity63 in @entity1 treated by ESAAR with stent grafts. Median length of stay was 1  day. One @entity1 treated by coil embolization developed @entity1188 , which required readmission for @entity158 control. Median follow-up was 9  months. Follow-up imaging in all successfully stented @entity1 revealed patent stent grafts, no endoleak, and no @entity439 sac enlargement. No reinterventions were required. CONCLUSIONS: ESAAR using self-expandable stent grafts offers a viable alternative to coil embolization in selected @entity1 with @entity438 . Distal @entity438 with excessive vessel tortuosity may result in technical failure requiring embolization. Among @entity1 who underwent successful ESAAR, there were no @entity63 , stent graft occlusions, @entity1070 , or sac enlargement.

Feasibility of endovascular repair of XXXX using stent grafts.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatitis'] @entity63 :: ('MESH:D007511', 'Disease') :: ['ischemic complications'] @entity1070 :: ('MESH:D057867', 'Disease') :: ['endoleaks'] @entity397 :: ('MESH:D012421', 'Disease') :: ['rupture'] @entity439 :: ('MESH:D000783', 'Disease') :: ['aneurysm'] @entity1188 :: ('MESH:D007238', 'Disease') :: ['splenic infarct'] @entity733 :: ('MESH:D000038', 'Disease') :: ['abscess'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity715 :: ('MESH:D013927', 'Disease') :: ['brachial artery thrombosis'] @entity5475 :: ('6287', 'Gene') :: ['SAA'] @entity360 :: ('MESH:D006471', 'Disease') :: ['gastrointestinal bleeding'] @entity438 :: ('MESH:D002532', 'Disease') :: ['splenic artery aneurysms', 'SAAs']
@entity438 :: (MESH:D002532,Disease) :: ['splenic artery aneurysms']
